Company Filing History:
Years Active: 2014
Title: Laura Redden: Innovator in Pharmaceutical Formulations
Introduction
Laura Redden is a prominent inventor based in Glenview, IL (US). She has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical formulations that enhance patient comfort and treatment efficacy.
Latest Patents
Laura Redden holds a patent for "High concentration anti-TNFα antibody liquid formulations." This invention provides a liquid aqueous pharmaceutical formulation comprising a human anti-TNFα antibody, or an antigen-binding portion thereof. The formulation is designed to reduce pain associated with injection in a subject by at least about 50% when compared to injecting an otherwise identical formulation comprising at least one salt and/or at least one buffer. Additionally, the invention offers increased bioavailability upon subcutaneous administration into a subject, which is crucial for therapeutic proteins such as human anti-TNF-alpha antibodies.
Career Highlights
Laura is associated with AbbVie Biotechnology Ltd., where she continues to innovate in the field of biopharmaceuticals. Her work focuses on improving the delivery and effectiveness of therapeutic agents, which is vital for patient care.
Collaborations
Some of her notable coworkers include Michael Neu and Markus Tschoepe, who contribute to the collaborative environment that fosters innovation at AbbVie.
Conclusion
Laura Redden's work exemplifies the impact of innovative pharmaceutical formulations on patient treatment. Her contributions are paving the way for advancements in biotechnology and improving the quality of life for many patients.